简介：
Overview
This article presents a hindlimb ischemia experimental model designed to evaluate the effectiveness of angiogenic therapies through functional, histologic, and molecular assessments. The protocol aims to establish a foundation for testing potential angiogenic agents in a small animal model.
Key Study Components
Area of Science
- Neuroscience
- Angiogenesis
- Ischemia
Background
- Revascularization is unsuitable for 20-30% of critical ischemia patients.
- Therapeutic angiogenesis is a novel strategy to improve blood perfusion.
- The study aims to understand the mechanisms of angiogenic therapies.
- This model could have future clinical applications.
Purpose of Study
- To assess the functional effects of angiogenic therapies.
- To evaluate histologic changes in response to treatment.
- To analyze molecular outcomes of angiogenic agents.
Methods Used
- Establishment of a hindlimb ischemia model in mice.
- Functional assessments using toe pinch response.
- Histological analysis post-treatment.
- Molecular testing to evaluate therapy efficacy.
Main Results
- Demonstrated the model's effectiveness in assessing angiogenic therapies.
- Provided insights into the functional and histological outcomes.
- Identified potential mechanisms of action for angiogenic agents.
- Supported future clinical applications of the findings.
Conclusions
- The hindlimb ischemia model is a valuable tool for research.
- Angiogenic therapies show promise in improving ischemic conditions.
- Further studies are needed to explore clinical implications.
What is hindlimb ischemia?
Hindlimb ischemia is a condition characterized by reduced blood flow to the hind limbs, often due to arterial blockages.
Why is angiogenesis important in ischemia?
Angiogenesis can restore blood flow to ischemic tissues, improving healing and function.
What are the potential applications of this research?
The findings could lead to new treatments for patients with critical limb ischemia.
How does the model assess therapy effectiveness?
The model evaluates functional, histological, and molecular responses to angiogenic therapies.
What are the next steps in this research?
Future studies will focus on translating findings to clinical settings and exploring additional therapies.
繁體中文
